Trial Profile

RCT comparing the levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation in women suffering from menorrhagia (MIRA)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Levonorgestrel (Primary)
Indications Menorrhagia
Focus Therapeutic Use
Acronyms MIRA

Most Recent Events

10 Jul 2021 Results evaluating the costs and non-inferiority of a strategy starting with the LNG-IUS compared to endometrial ablation in the treatment of heavy menstrual bleeding, published in the BJOG: An International Journal of Obstetrics and Gynaecology
11 Aug 2020 Status changed from not yet recruiting to completed, as per results published in the American Journal of Obstetrics and Gynecology
11 Aug 2020 Primary endpoint (blood loss at 24 months) has not been met, as per Results published in the American Journal of Obstetrics and Gynecology

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com